Track topics on Twitter Track topics that are important to you
Dallas, Texas (PRWEB) August 08, 2017
VitreosHealth™, the Predictive Healthcare Insights company, announced today that it was listed in two recent Gartner Hype Cycle Reports: Hype Cycle for U.S. Healthcare Payers, 2017 and Hype Cycle for Consumer Engagement With Healthcare and Wellness, 2017.
Gartner identified VitreosHealth as a sample vendor for Healthcare Consumer Insight as a Service (HCIaaS). According to Gartner’s Hype Cycle for Healthcare Consumer Insight as a Service, 2017, “in recent years, HCIaaS has emerged to offer a faster, more efficient path to value.” Gartner identified specific benefits that can be realized from HCIaaS. “HCIaaS offers a mechanism to gain the unique value of advanced analytics at the individual-consumer level, without the requirements of large data sets, on-premises integration of partner data sources, in-house data science talent, advanced analytics platform technology, and decision hub architecture for putting predictions into workflow.” The report further states that “Healthcare CIOs, IT leaders and analytics leaders should consider HCIaaS an emerging, and potentially crucial, component in developing their enterprise analytics strategy.”
"We believe that VitreosHealth being cited in Gartner Hype Cycle report further validates the importance of Predictive & Prescriptive Insights-as-Service and its positive and immediate impact on providers, health plans, and self-insured employers,” said Jay Reddy, CEO of VitreosHealth. “Our IaaS platform along with State-of-Health Analysis (SOHA) program drastically lowers the barriers to entry for advanced analytics (including AI) for population health programs.”
(1) Gartner, Inc. “Hype Cycle for U.S. Healthcare Payers, 2017” by Brad Holmes, Jeff Cribbs, Bryan Cole, July 14, 2017
(2) Gartner, Inc. “Hype Cycle for Consumer Engagement With Healthcare and Wellness, 2017”, Mark E. Gilbert, Jeff Cribbs, July 19, 2017
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
VitreosHealth is the source for adaptive insights into population health management to deliver meaningful outcomes. As a pioneer of Advanced Population Health analytics for Big Data, we leverage the broadest set of data sources including EHR, claims, HRAs, socioeconomic and well-being data for predictive risk and prescriptive care management.
We offer this through the first healthcare Insights-as-a-Service (IaaS) delivery model for population risk models, and predictive and prescriptive health insights for a complete view into the healthcare continuum. Each “insights-view” achieves a patient-centric focus from every stakeholder perspective within the healthcare organization that will contribute to quality health outcomes and improved financial performance. VitreosHealth is changing the economics of healthcare for our clients.
VitreosHealth has won numerous awards including Frost & Sullivan recognized VitreosHealth with the 2016 North America Frost & Sullivan Award for New Product Innovation, and has been featured in prominent research and publications like 2017 PWC Report: “Why AI and robotics will define new health.”
For the original version on PRWeb visit: http://www.prweb.com/releases/2017/08/prweb14576342.htmNEXT ARTICLE
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...